Skip to main content
PMC home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1995 Sep;40(3):237–243. doi: 10.1111/j.1365-2125.1995.tb05779.x

The effect of human chorionic gonadotropin (HCG) in the treatment of obesity by means of the Simeons therapy: a criteria-based meta-analysis.

G K Lijesen 1, I Theeuwen 1, W J Assendelft 1, G Van Der Wal 1
PMCID: PMC1365103  PMID: 8527285

Abstract

1. A meta-analysis was conducted to assess if there is scientific ground for the use of human chorionic gonadotropin (HCG) as adjunctive therapy in the treatment of obesity. 2. Published papers relating to eight controlled and 16 uncontrolled trials that measured the effect of HCG in the treatment of obesity were traced by computer-aided search and citation tracking. 3. The trials were scored for the quality of the methods (based on four main categories: study population, interventions, measurement of effect, and data presentation and analysis) and the main conclusion of author(s) with regard to weight-loss, fat-redistribution, hunger, and feeling of well-being. 4. Methodological scores ranged from 16 to 73 points (maximum score 100), suggesting that most studies were of poor methodological quality. Of the 12 studies scoring 50 or more points, one reported that HCG was a useful adjunct. The studies scoring 50 or more points were all controlled. 5. We conclude that there is no scientific evidence that HCG is effective in the treatment of obesity; it does not bring about weight-loss of fat-redistribution, nor does it reduce hunger or induce a feeling of well-being.

Full text

PDF
239

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Albrink M. J. Chorionic gonadotropin and obesity? Am J Clin Nutr. 1969 Jun;22(6):681–685. doi: 10.1093/ajcn/22.6.681. [DOI] [PubMed] [Google Scholar]
  2. Asher W. L., Harper H. W. Effect of human chorionic gonadotrophin on weight loss, hunger, and feeling of well-being. Am J Clin Nutr. 1973 Feb;26(2):211–218. doi: 10.1093/ajcn/26.2.211. [DOI] [PubMed] [Google Scholar]
  3. Asher W. L., Harper H. W. Letter: Human chorionic gonadotropin treatment for obesity: a rebuttal. Am J Clin Nutr. 1974 May;27(5):450–455. doi: 10.1093/ajcn/27.5.450. [DOI] [PubMed] [Google Scholar]
  4. BUTTURINI U. Sulla terapia della obesità costituzionale con la gonadotropina corionica. Riforma Med. 1957 Feb 9;71(6):146–149. [PubMed] [Google Scholar]
  5. Ballin J. C., White P. L. Fallacy and hazard. Human chorionic gonadotropin-500-calorie diet and weight reduction. JAMA. 1974 Nov 4;230(5):693–694. doi: 10.1001/jama.230.5.693. [DOI] [PubMed] [Google Scholar]
  6. Berger M., Berchtold P., Jörgens V., Solbach H. G., Zimmermann H. Ist die HCG-Therapie der Fettsucht sinnvoll? Med Klin. 1980 Aug 15;75(17):624–625. [PubMed] [Google Scholar]
  7. Birmingham C. L., Smith K. C. Human chorionic gonadotropin is of no value in the management of obesity. Can Med Assoc J. 1983 May 15;128(10):1156–1157. [PMC free article] [PubMed] [Google Scholar]
  8. Bosch B., Venter I., Stewart R. I., Bertram S. R. Human chorionic gonadotrophin and weight loss. A double-blind, placebo-controlled trial. S Afr Med J. 1990 Feb 17;77(4):185–189. [PubMed] [Google Scholar]
  9. Bradley P. 'The equilibrium set-point weight: human chorionic gonadotrophin and obesity'. Int J Obes. 1979;3(4):380–389. [PubMed] [Google Scholar]
  10. Bradley P. Human chorionic gonadotropin in weight reduction. Am J Clin Nutr. 1977 May;30(5):649–654. doi: 10.1093/ajcn/30.5.649. [DOI] [PubMed] [Google Scholar]
  11. CARNE S. The action of chorionic gonadotrophin in the obese. Lancet. 1961 Dec 9;2(7215):1282–1284. doi: 10.1016/s0140-6736(61)91142-4. [DOI] [PubMed] [Google Scholar]
  12. CRAIG L. S., RAY R. E., WAXLER S. H., MADIGAN H. Chorionic gonadotropin in the treatment of obese women. Am J Clin Nutr. 1963 Mar;12:230–234. doi: 10.1093/ajcn/12.3.230. [DOI] [PubMed] [Google Scholar]
  13. Chalmers T. C., Smith H., Jr, Blackburn B., Silverman B., Schroeder B., Reitman D., Ambroz A. A method for assessing the quality of a randomized control trial. Control Clin Trials. 1981 May;2(1):31–49. doi: 10.1016/0197-2456(81)90056-8. [DOI] [PubMed] [Google Scholar]
  14. Easterbrook P. J., Berlin J. A., Gopalan R., Matthews D. R. Publication bias in clinical research. Lancet. 1991 Apr 13;337(8746):867–872. doi: 10.1016/0140-6736(91)90201-y. [DOI] [PubMed] [Google Scholar]
  15. FRANK B. W. THE USE OF CHORIONIC GONADOTROPIN HORMONE IN THE TREATMENT OF OBESITY. A DOUBLE-BLIND STUDY. Am J Clin Nutr. 1964 Mar;14:133–136. doi: 10.1093/ajcn/14.3.133. [DOI] [PubMed] [Google Scholar]
  16. Faludi G. Use of chorionic gonadotropins in obesity. Am Fam Physician. 1975 May;11(5):156–157. [PubMed] [Google Scholar]
  17. Goodman S. N. Have you ever meta-analysis you didn't like? Ann Intern Med. 1991 Feb 1;114(3):244–246. doi: 10.7326/0003-4819-114-3-244. [DOI] [PubMed] [Google Scholar]
  18. Greenway F. L., Bray G. A. Human chorionic gonadotropin (HCG) in the treatment of obesity: a critical assessment of the Simeons method. West J Med. 1977 Dec;127(6):461–463. [PMC free article] [PubMed] [Google Scholar]
  19. Gusman H. A. Chorionic gonadotropin in obesity. Further clinical observations. Am J Clin Nutr. 1969 Jun;22(6):686–695. doi: 10.1093/ajcn/22.6.686. [DOI] [PubMed] [Google Scholar]
  20. HARRIS J. M., WARSAW E. OBESITY: A PROBLEM WITH MANY FACETS: OBSERVATIONS ON TREATMENT WITH CHORIONIC GONADOTROPIN AS AN ADJUNCT TO DIETARY MEASURES. J Am Geriatr Soc. 1964 Oct;12:987–995. doi: 10.1111/j.1532-5415.1964.tb00644.x. [DOI] [PubMed] [Google Scholar]
  21. HASTRUP B., NIELSEN B., SKOUBY A. P. Chorionic gonadotropin and the treatment of obesity. Acta Med Scand. 1960 Sep 21;168:25–27. doi: 10.1111/j.0954-6820.1960.tb06636.x. [DOI] [PubMed] [Google Scholar]
  22. Hutton J. H., Creticos A. P. Human chorionic gonadotropin (HCG) in treatment of obesity. IMJ Ill Med J. 1967 Nov;132(5):693–695. [PubMed] [Google Scholar]
  23. Koes B. W., Assendelft W. J., van der Heijden G. J., Bouter L. M., Knipschild P. G. Spinal manipulation and mobilisation for back and neck pain: a blinded review. BMJ. 1991 Nov 23;303(6813):1298–1303. doi: 10.1136/bmj.303.6813.1298. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. LEBON P. Treatment of overweight patients with chorionic gonadotropin. J Am Geriatr Soc. 1961 Nov;9:998–1002. doi: 10.1111/j.1532-5415.1961.tb00443.x. [DOI] [PubMed] [Google Scholar]
  25. Maudlin R. K. Gonadotropins in obesity? Am Fam Physician. 1973 Oct;8(4):202–203. [PubMed] [Google Scholar]
  26. Miller R., Schneiderman L. J. A clinical study of the use of human chorionic gonadotrophin in weight reduction. J Fam Pract. 1977 Mar;4(3):445–448. [PubMed] [Google Scholar]
  27. Perelberg H. Chorionic gonadotrophin (HCG) and obesity. Med J Aust. 1977 Jul 9;2(2):68–69. [PubMed] [Google Scholar]
  28. Rabe T., Richter S., Kiesel L., Runnebaum B. Risiko-Nutzen-Analyse einer hCG-500-kcal-Reduktionsdiät (Cura romana) bei Frauen. Geburtshilfe Frauenheilkd. 1987 May;47(5):297–307. doi: 10.1055/s-2008-1035826. [DOI] [PubMed] [Google Scholar]
  29. SIMEONS A. T. CHORIONIC GONADOTROPHIN IN THE TREATMENT OF OBESE WOMEN. Am J Clin Nutr. 1963 Sep;13:197–198. doi: 10.1093/ajcn/13.3.197-a. [DOI] [PubMed] [Google Scholar]
  30. SIMEONS A. T. CHORIONIC GONADOTROPHIN IN THE TREATMENT OF OBESITY. Am J Clin Nutr. 1964 Sep;15:188–190. doi: 10.1093/ajcn/15.3.188. [DOI] [PubMed] [Google Scholar]
  31. SIMEONS A. T. The action of chorionic gonadotrophin in the obese. Lancet. 1954 Nov 6;267(6845):946–947. doi: 10.1016/s0140-6736(54)92556-8. [DOI] [PubMed] [Google Scholar]
  32. SOHAR E. A forty-day-550 calorie diet in the treatment of obese outpatients. Am J Clin Nutr. 1959 Sep-Oct;7:514–518. doi: 10.1093/ajcn/7.5.514. [DOI] [PubMed] [Google Scholar]
  33. Shetty K. R., Kalkhoff R. K. Human chorionic gonadotropin (HCG) treatment of obesity. Arch Intern Med. 1977 Feb;137(2):151–155. [PubMed] [Google Scholar]
  34. Stein M. R., Julis R. E., Peck C. C., Hinshaw W., Sawicki J. E., Deller J. J., Jr Ineffectiveness of human chorionic gonadotropin in weight reduction: a double-blind study. Am J Clin Nutr. 1976 Sep;29(9):940–948. doi: 10.1093/ajcn/29.9.940. [DOI] [PubMed] [Google Scholar]
  35. Van Itallie T. B., Hirsch J. Letter: The treatment of obesity. Am J Clin Nutr. 1973 Oct;26(10):1039–1041. doi: 10.1093/ajcn/26.10.1039. [DOI] [PubMed] [Google Scholar]
  36. Veilleux H., Fortin Z. Effets gonadiques et extragonadiques, chez l'humain, de 3500 U.I. de HCG (gonadotrophine chorionique humaine) en doses fractionnées. Vie Med Can Fr. 1972 Sep;1(9):862–871. [PubMed] [Google Scholar]
  37. Vogt T., Belluscio D. Controversies in plastic surgery: suction-assisted lipectomy (SAL) and the hCG (human chorionic gonadotropin) protocol for obesity treatment. Aesthetic Plast Surg. 1987;11(1):131–156. doi: 10.1007/BF01575502. [DOI] [PubMed] [Google Scholar]
  38. Young R. L., Fuchs R. J., Woltjen M. J. Chorionic gonadotropin in weight control. A double-blind crossover study. JAMA. 1976 Nov 29;236(22):2495–2497. [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES